Page last updated: 2024-11-05

mepiperphenidol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Mepiperphenidol is a synthetic anticholinergic drug that acts as a muscarinic acetylcholine receptor antagonist. It was initially developed in the 1950s as a potential treatment for Parkinson's disease and other movement disorders. While it showed some effectiveness in clinical trials, its use has been limited due to its significant side effects, including dry mouth, blurred vision, constipation, and urinary retention. Mepiperphenidol's mechanism of action involves blocking the binding of acetylcholine to muscarinic receptors, which are found in various tissues throughout the body, including the brain, heart, and gastrointestinal tract. Its synthesis involves a multi-step process starting with the reaction of 1-methylpiperidine with a suitable benzoyl chloride derivative. Mepiperphenidol is still studied in research settings to explore its potential therapeutic applications, particularly in combination with other drugs. The primary reason for studying mepiperphenidol is to better understand its pharmacological properties and to explore its potential as a therapeutic agent, particularly in combination with other drugs. Current research focuses on exploring its potential role in treating movement disorders, Alzheimer's disease, and other neurological conditions.'

Cross-References

ID SourceID
PubMed CID10620
CHEMBL ID2078910
CHEBI ID135211
MeSH IDM0056004

Synonyms (14)

Synonym
mepiperphenidol
CHEBI:135211
5-methyl-1-(1-methylpiperidin-1-ium-1-yl)-4-phenylhexan-3-ol
bdbm50420216
13004-75-6
piperidinium, 1-(3-hydroxy-5-methyl-4-phenylhexyl)-1-methyl-
8i07j24f45 ,
unii-8i07j24f45
mepiperphenidol ion
mepiperphenidol cation
CHEMBL2078910
Q27270560
1-(3-hydroxy-5-methyl-4-phenylhexyl)-1-methylpiperidin-1-ium
DTXSID601043665
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
organic amino compoundA compound formally derived from ammonia by replacing one, two or three hydrogen atoms by organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (68.75)18.7374
1990's5 (31.25)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.40 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.35 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]